Mn Services Vermogensbeheer B.V. lowered its stake in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 2.6% during the second quarter, Holdings Channel reports. The fund owned 90,300 shares of the biopharmaceutical company’s stock after selling 2,400 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Incyte were worth $5,621,000 at the end […]
Incyte (NASDAQ:INCY – Free Report) had its price objective lowered by Royal Bank of Canada from $74.00 to $63.00 in a research report sent to investors on Wednesday, Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the biopharmaceutical company’s stock. INCY has been the topic of several other research reports. […]
Incyte (NASDAQ:INCY – Free Report) had its price target decreased by Morgan Stanley from $74.00 to $64.00 in a research report released on Wednesday, Benzinga reports. Morgan Stanley currently has an equal weight rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on INCY. Royal Bank of Canada raised […]
Incyte Co. (NASDAQ:INCY – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $50.27 and last traded at $51.40, with a volume of 430311 shares traded. The stock had previously closed at $52.16. Analysts Set New Price Targets INCY has been the […]
JGP Global Gestao de Recursos Ltda. lifted its position in Incyte Co. (NASDAQ:INCY – Free Report) by 1,370.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,469 shares of the biopharmaceutical company’s stock after buying an additional 11,621 shares during the quarter. […]